These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11596572)

  • 21. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
    Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
    Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.
    Chung NG; Lee JW; Jang PS; Jeong DC; Cho B; Kim HK
    Pediatr Transplant; 2013 Jun; 17(4):387-93. PubMed ID: 23551397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [High-dose cyclophosphamide for severe aplastic anemia associated with β-thalassemia: a case report and literatures review].
    Zhao X; Li Y; Zhou K; Zhang L; Jing LP; Ye L; Peng GX; Li Y; Li JP; Fan HH; Song L; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):532-5. PubMed ID: 23827114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
    Doney K; Leisenring W; Storb R; Appelbaum FR
    Ann Intern Med; 1997 Jan; 126(2):107-15. PubMed ID: 9005744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy.
    Arranz R; Otero MJ; Ramos R; Steegmann JL; Lamana ML; Tomás JF; de la Cámara R; Figuera A; Vázquez L; Fernádez-Rañada JM
    Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery from aplastic anemia after treatment with cyclophosphamide.
    Baran DT; Griner PF; Klemperer MR
    N Engl J Med; 1976 Dec; 295(27):1522-3. PubMed ID: 995159
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
    Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of a novel immunosuppressive strategy of cyclosporine, levamisole and danazol for severe aplastic anemia.
    Wang M; Li X; Shi J; Shao Y; Ge M; Huang J; Huang Z; Zhang J; Nie N; Zheng Y
    Int J Hematol; 2015 Aug; 102(2):149-56. PubMed ID: 26072293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
    Kötter I
    Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987
    [No Abstract]   [Full Text] [Related]  

  • 31. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.
    Kim H; Lee JH; Joo YD; Bae SH; Hyun MS; Lee JH; Kim DY; Lee WS; Ryoo HM; Kim MK; Park JH; Lee KH;
    Ann Hematol; 2012 Sep; 91(9):1459-69. PubMed ID: 22526363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens.
    Leleu X; Terriou L; Duhamel A; Moreau AS; Andrieux J; Dupire S; Coiteux V; Berthon C; Micol JB; Guieze R; Facon T; Bauters F
    Ann Hematol; 2006 Oct; 85(10):711-6. PubMed ID: 16830141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The treatment results in patients with aplastic anemia using different doses of antilymphocyte globulin].
    Abdulkadyrov KM; Ganapiev AA; Shilova ER; Popova TI; Rozanova OE; Katsadze IuL
    Ter Arkh; 1995; 67(8):51-4. PubMed ID: 7482337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
    Mori T; Koh H; Onishi Y; Kako S; Onizuka M; Kanamori H; Ozawa Y; Kato C; Iida H; Suzuki R; Ichinohe T; Kanda Y; Maeda T; Nakao S; Yamazaki H
    Int J Hematol; 2016 Apr; 103(4):461-8. PubMed ID: 26910242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.
    Gómez-Almaguer D; Vela-Ojeda J; Jaime-Pérez JC; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Sobrevilla-Calvo P; Rivas-Vera S; Gómez-Rangel JD; Ruiz-Argüelles GJ
    Am J Hematol; 2006 Mar; 81(3):157-61. PubMed ID: 16493614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ruptured Klebsiella pneumoniae liver abscess after high-dose cyclophosphamide for severe aplastic anemia.
    Lee JJ; Kim HJ; Chung IJ; Kook H; Park MR; Kim CJ; Shin DH; Hwang TJ
    Am J Hematol; 2000 Jul; 64(3):218-20. PubMed ID: 10861821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
    de Groot K; Harper L; Jayne DR; Flores Suarez LF; Gregorini G; Gross WL; Luqmani R; Pusey CD; Rasmussen N; Sinico RA; Tesar V; Vanhille P; Westman K; Savage CO;
    Ann Intern Med; 2009 May; 150(10):670-80. PubMed ID: 19451574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
    Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
    Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia.
    Dorr V; Doolittle G; Woodroof J
    Am J Hematol; 1996 Jun; 52(2):108-13. PubMed ID: 8638630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of aplastic anaemia secondary to systemic lupus erythematosus by high-dose intravenous cyclophosphamide.
    Walport MJ; Hubbard WN; Hughes GR
    Br Med J (Clin Res Ed); 1982 Sep; 285(6344):769-70. PubMed ID: 6810992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.